Bexarotene
Top View
- Clinically Relevant Concentrations of Anticancer Drugs: a Guide for Nonclinical Studies Dane R
- PDF-Document
- Retinoids (Acitretin, Adapalene, Alitretinoin, Bexarotene, Isotretinoin, Tazarotene and Tretinoin) – Update on Teratogenicity and Neuropsychiatric Disorders
- Targretin, Bexarotene, Belongs to a Group of Medicines Known As Retinoids, Which Are Related to Vitamin A
- List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
- Principles of Antineoplastic Therapy
- Targeting TR4 Nuclear Receptor with Antagonist Bexarotene Increases
- Prevents and Overcomes Acquired Paclitaxel (Taxol) Resistance in Human Non–Small Cell Lung Cancer
- Acitretin, Adapalene, Alitretinoin, Bexarotene, Isotretinoin, Tretinoin and Tazarotene) ΠUpdate on Teratogenicity and Neuropsychiatric Disorders
- List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
- Istodax Prior Authorization Request Form
- Early Stage Treatment Options Theresa Pacheco, Md
- Alitretinoin for the Treatment of Chronic Hand Eczema: Clinical Rationale
- Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy
- Synergistic Effect of a Retinoid X Receptor-Selective Ligand Bexarotene and Docetaxel in Prostate Cancer
- Photodegradation of Bexarotene and Its Implication for Cytotoxicity
- 2713-5, 25 Mitomycin C
- Systematic Development of Small Molecules to Inhibit Specific Microscopic Steps of Aβ42 Aggregation in Alzheimer’S Disease